Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.O)

ADAP.O on Nasdaq

3.67USD
17 May 2019
Change (% chg)

$-0.02 (-0.54%)
Prev Close
$3.69
Open
$3.70
Day's High
$3.75
Day's Low
$3.62
Volume
200,057
Avg. Vol
303,880
52-wk High
$14.54
52-wk Low
$3.55

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $384.35
Shares Outstanding(Mil.): 104.73
Dividend: --
Yield (%): --

Financials

  ADAP.O Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -1.02 -- --
ROI: -46.22 7.41 11.59
ROE: -49.74 7.88 16.33

Earnings vs. Estimates